Race of GLPS: Impact on Weight and Glycemic Control on Type 2 Diabetes with Semaglutide Versus Liraglutide
OBJECTIVES Semaglutide is a glucagon-like peptide-1 receptor agonist that improves glycemic control and reduces body weight in patients with type 2 diabetes. This study aimed to evaluate the effect of Semaglutide with standard Metformin on glycemic control and BMI after 3 and 6 months of treatmen...
Saved in:
| Main Authors: | Noha Hafeez, Fatima Jehanghir, Aroosa Altaf, Huma Akbar Jafri, Tariq Adnan, Faiza Rani Ahmed, Naureen Kazim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Gandhara University
2024-12-01
|
| Series: | Journal of Gandhara Medical and Dental Sciences |
| Subjects: | |
| Online Access: | https://jgmds.org.pk/index.php/JGMDS/article/view/633 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity and reproductive health: “nocturne” to modern comorbidity
by: Mekan R. Orazov, et al.
Published: (2024-09-01) -
Semaglutide, liraglutide and tirzepatide: Comparison of effectiveness in the treatment of obesity – a literature review
by: Karolina Baran, et al.
Published: (2024-12-01) -
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review
by: Serene Lee, et al.
Published: (2024-11-01) -
The effects of liraglutide on the characteristics of blood parameters and testicular tissue induced diabetes and obesity in mice
by: Saied Mohammadzadeh, et al.
Published: (2024-08-01) -
Spotlight on the Mechanism of Action of Semaglutide
by: Ilias Papakonstantinou, et al.
Published: (2024-12-01)